Astellas Pharma Inc. (OTCPK:ALPMF) Q3 2024 Earnings Conference Call February 4, 2025 2:00 AM ET
Company Participants
Hiromitsu Ikeda – Chief Communications and IR Officer
Atsushi Kitamura – Chief Financial Officer
Tadaaki Taniguchi – Chief Medical Officer
Claus Zieler – Chief Commercial Officer
Conference Call Participants
Hidemaru Yamaguchi – Citigroup Securities
Seiji Wakao – JPMorgan Securities
Shinichiro Muraoka – Morgan Stanley MUFG Securities
Akinori Ueda – Goldman Sachs Securities
Hiroyuki Matsubara – Nomura Securities
Shinichiro Hyogo – Mitsubishi UFJ Trust Bank
Miki Sogi – Sanford C. Berstein
Fumiyoshi Sakai – UBS Securities
Kazuaki Hashiguchi – Daiwa Securities
Hiromitsu Ikeda
Thank you very much for your attendance on to this Q3 Y-to-D FY ’24 Financial Results Announcement Meeting. I’m going to serve as a moderator. I’m from — I’m Communication — Chief Communications and IR Officer, Ikeda.
We’ll make a presentation first, and after that, we’ll have a Q&A session. The presentation is given based upon the presentation material posted on our website, including a Q&A. The simultaneous translation for both Japanese and English are provided. For the simultaneous translation, the accuracy cannot be guaranteed by us, the company. You can select the language from Zoom webinar screen menu. If you select the original language, then you can hear the original sounds without the interpreters’ voices.
This is some disclaimer. This material or presentation by representatives for the company and answers and statement by representatives for the company in the Q&A session includes forward-looking statements based on assumptions and beliefs in light of the information currently available to management and subject to significant risks and uncertainties.
Actual financial results may differ materially depending on a number of factors. They contain information on pharmaceuticals, including compounds under development. This information is not intended to make any representations or advertisements regarding the efficacy or effectiveness of
Read the full article here
